Old, new drugs and new, new drugs for the new millennium David A. Scheinberg Clinical Trials Review Pages: 112 - 113
Molecular biology of leukemia Andrzej JakubowiakJorg CammengaStephen D. Nimer OriginalPaper Pages: 123 - 131
Allogeneic hematopoietic transplantation for acute and chronic myeloid leukemia: Non-myeloablative preparative regimens and induction of the graft-versus-leukemia effect Avichai ShimoniSergio GiraltRichard Champlin OriginalPaper Pages: 132 - 139
Critical evaluation of the World Health Organization classification of myelodysplasia and acute myeloid leukemia Mark L. HeaneyDavid W. Golde OriginalPaper Pages: 140 - 143
Biologic and clinical aspects of autologous stem cell transplantation with mobilized peripheral blood cells in chronic myelogenous leukemia Francesco Frassoni OriginalPaper Pages: 144 - 151
New developments in lymphoma clinical trials Carol S. Portlock Clinical Trials Review Pages: 154 - 156
Hodgkin’s disease: Prognostic factors and short-course regimens Nancy L. BartlettSophia M. Arackal OriginalPaper Pages: 163 - 171
Hepatitis C and lymphoma Federico SilvestriAlessandra SperottoRenato Fanin OriginalPaper Pages: 172 - 175
Combined chemotherapy plus radiotherapy for treatment of earlystage intermediate- and high-grade non-Hodgkin’s lymphoma Jonathan H. BriggsThomas P. Miller OriginalPaper Pages: 176 - 181
Allogeneic hematopoietic transplantation for chronic lymphocytic leukemia and lymphoma: Potential for nonablative preparative regimens Richard ChamplinKoen van BesienIssa Khouri OriginalPaper Pages: 182 - 191
Mucosa-associated lymphoid tissue lymphomas Mary GospodarowiczRichard Tsang OriginalPaper Pages: 192 - 198